|
⚲
|
| Keyboard |
| Horowitz Limited Partnership VIII
✚
|
|
|---|---|
| CIK # | 0001827839 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001827839] | |
| 4 | [0001827839] | |
| SC 13D | [0001827839] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Horowitz Limited Partnership VIII | Tarsus Pharmaceuticals Inc | [2020-10-30] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Tarsus Pharmaceuticals Inc | |
| Horowitz Limited Partnership VIII |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Tarsus Pharmaceuticals Inc TARS
Common Stock
|
2020-10-20 | Conversion | 43,151 | ||
|
Tarsus Pharmaceuticals Inc TARS
Common Stock
|
2020-10-20 | Buy | 168,750 | $16.00 | 2,700,000 |
|
Tarsus Pharmaceuticals Inc TARS
Common Stock
|
2020-10-20 | Conversion | 7,396 | ||
|
Tarsus Pharmaceuticals Inc TARS
Common Stock
|
2020-10-20 | Buy | 15,625 | $16.00 | 250,000 |
|
Tarsus Pharmaceuticals Inc TARS
Common Stock
|
2020-10-20 | Conversion | 245,966 | ||
|
Tarsus Pharmaceuticals Inc TARS
Common Stock
|
2020-10-20 | Conversion | 1,434,790 | ||
|
Tarsus Pharmaceuticals Inc TARS
Common Stock
|
2020-10-20 | Conversion | 71,427 | ||
|
Tarsus Pharmaceuticals Inc TARS
Series B Preferred Stock · derivative
|
2020-10-20 | Conversion | 7,396 | ||
|
Tarsus Pharmaceuticals Inc TARS
Series B Preferred Stock · derivative
|
2020-10-20 | Conversion | 245,966 | ||
|
Tarsus Pharmaceuticals Inc TARS
Series C Preferred Stock · derivative
|
2020-10-20 | Conversion | 71,427 | ||
|
Tarsus Pharmaceuticals Inc TARS
Series A Preferred Stock · derivative
|
2020-10-20 | Conversion | 43,151 | ||
|
Tarsus Pharmaceuticals Inc TARS
Series A Preferred Stock · derivative
|
2020-10-20 | Conversion | 1,434,790 |